POLYCLONAL SERUM IGM AS A PROGNOSTIC MARKER IN NEWLY DIAGNOSED MULTIPLE MYELOMA

MLA

Napolitano, M., et al. Polyclonal Serum Igm as a Prognostic Marker in Newly Diagnosed Multiple Myeloma. Jan. 2016. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..6f84a21a8a0c99106df21f520288e4c7&authtype=sso&custid=ns315887.

APA

Napolitano, M., Montante, C., Saccullo, G., Mancuso, S., Cariccio, M. R. L., Malato, A., Fabbiano, F., Alessandro Lucchesi, Pagan, F., Conticello, C., Mannina, D., Di Raimondo, F., & Siragusa, S. (2016). Polyclonal Serum Igm as a Prognostic Marker in Newly Diagnosed Multiple Myeloma.

Chicago

Napolitano, M., C. Montante, G. Saccullo, S. Mancuso, M. R. Lanza Cariccio, A. Malato, F. Fabbiano, et al. 2016. “Polyclonal Serum Igm as a Prognostic Marker in Newly Diagnosed Multiple Myeloma,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..6f84a21a8a0c99106df21f520288e4c7&authtype=sso&custid=ns315887.